Stem cell- derived extracellular vesicles as new tools in regenerative medicine - Immunomodulatory role and future perspectives
Open Access
- 24 January 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1120175
Abstract
In the last few decades, the practical use of stem cells (SCs) in the clinic has attracted significant attention in the regenerative medicine due to the ability of these cells to proliferate and differentiate into other cell types. However, recent findings have demonstrated that the therapeutic capacity of SCs may also be mediated by their ability to secrete biologically active factors, including extracellular vesicles (EVs). Such submicron circular membrane-enveloped vesicles may be released from the cell surface and harbour bioactive cargo in the form of proteins, lipids, mRNA, miRNA, and other regulatory factors. Notably, growing evidence has indicated that EVs may transfer their bioactive content into recipient cells and greatly modulate their functional fate. Thus, they have been recently envisioned as a new class of paracrine factors in cell-to-cell communication. Importantly, EVs may modulate the activity of immune system, playing an important role in the regulation of inflammation, exhibiting broad spectrum of the immunomodulatory activity that promotes the transition from pro-inflammatory to pro-regenerative environment in the site of tissue injury. Consequently, growing interest is placed on attempts to utilize EVs in clinical applications of inflammatory-related dysfunctions as potential next-generation therapeutic factors, alternative to cell-based approaches. In this review we will discuss the current knowledge on the biological properties of SC-derived EVs, with special focus on their role in the regulation of inflammatory response. We will also address recent findings on the immunomodulatory and pro-regenerative activity of EVs in several disease models, including in vitro and in vivo preclinical, as well as clinical studies. Finally, we will highlight the current perspectives and future challenges of emerging EV-based therapeutic strategies of inflammation-related diseases treatment.Keywords
Funding Information
- Narodowe Centrum Badań i Rozwoju
- Narodowe Centrum Nauki
- Narodowe Centrum Nauki
This publication has 289 references indexed in Scilit:
- Microvesicles Derived from Human Umbilical Cord Wharton’s Jelly Mesenchymal Stem Cells Attenuate Bladder Tumor Cell Growth In Vitro and In VivoPLOS ONE, 2013
- The Tetraspanin CD63 Regulates ESCRT-Independent and -Dependent Endosomal Sorting during MelanogenesisDevelopmental Cell, 2011
- Definition of ALI/ARDSCritical Care Clinics, 2011
- Ectosomes Released by Polymorphonuclear Neutrophils Induce a MerTK-dependent Anti-inflammatory Pathway in MacrophagesJournal of Biological Chemistry, 2010
- A Novel Nanoparticle Drug Delivery System: The Anti-inflammatory Activity of Curcumin Is Enhanced When Encapsulated in ExosomesMolecular Therapy, 2010
- ARF6-Regulated Shedding of Tumor Cell-Derived Plasma Membrane MicrovesiclesCurrent Biology, 2009
- Therapeutic effect of exosomes from indoleamine 2,3‐dioxygenase–positive dendritic cells in collagen‐induced arthritis and delayed‐type hypersensitivity disease modelsArthritis & Rheumatism, 2009
- Cellular and Molecular Mechanisms of Liver InjuryGastroenterology, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007
- Alzheimer's disease beta-amyloid peptides are released in association with exosomesProceedings of the National Academy of Sciences of the United States of America, 2006